Noelia Cantero-Garcia
Overview
Explore the profile of Noelia Cantero-Garcia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pineda-Gomez J, Millon C, Cantero-Garcia N, Flores-Gomez M, de Guevara-Miranda D, Flores-Burgess A, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2024 Nov;
136():111191.
PMID: 39522791
Major depressive disorder affects more than 50 million people in the world. However, 50% of patients don't respond to two or more drugs or psychotherapeutic treatments, named treatment-resistant depression (TRD)....
2.
Flores-Burgess A, Millon C, Cantero-Garcia N, Pineda-Gomez J, Flores-Gomez M, Diaz-Cabiale Z
Curr Neuropharmacol
. 2024 Nov;
23(3):295-309.
PMID: 39484753
Depression is one of the most disabling mental disorders, with the second highest social burden; its prevalence has grown by more than 27% in recent years, affecting 246 million in...
3.
Cantero-Garcia N, Flores-Burgess A, Pineda-Gomez J, Orio L, Serrano A, Diaz-Cabiale Z, et al.
Biomed Pharmacother
. 2022 Sep;
153:113508.
PMID: 36076594
Alcohol Use Disorder (AUD) is among the most prevalent mental illnesses, and due to the low efficacy of the current medication, it is essential to find new biological targets that...
4.
Cantero-Garcia N, Flores-Burgess A, de Guevara-Miranda D, Serrano A, Garcia-Duran L, Puigcerver A, et al.
Biomedicines
. 2022 Feb;
10(2).
PMID: 35203621
Alcohol use disorder (AUD) is highly prevalent, and over 50% of AUD patients also suffer major depressive disorders. Selective 5-HT reuptake inhibitors (SSRIs) can reduce rodent ethanol drinking but exert...
5.
Flores-Burgess A, Millon C, Gago B, Garcia-Duran L, Cantero-Garcia N, Puigcerver A, et al.
Int J Neuropsychopharmacol
. 2021 Dec;
25(4):307-318.
PMID: 34891163
Background: Selective serotonergic reuptake inhibitors, including fluoxetine (FLX), are the most commonly used for the treatment of major depression. However, they are effective for remission in only 30% of patients....
6.
Garcia-Duran L, Flores-Burgess A, Cantero-Garcia N, Puigcerver A, Narvaez J, Fuxe K, et al.
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34639188
Selective 5-HT reuptake inhibitor antidepressants (SSRIs) are the first choice in major depressive disorder (MDD), but 50% of affected patients do not show improvement. Galanin(1-15) [GAL(1-15)] enhanced Fluoxetine antidepressant-like effects...
7.
Flores-Burgess A, Millon C, Gago B, Garcia-Duran L, Cantero-Garcia N, Covenas R, et al.
Neuropharmacology
. 2019 May;
155:104-112.
PMID: 31128121
Galanin (1-15) [GAL(1-15)] participates in mood regulation and depression. GAL(1-15) is also able to enhance the antidepressant effects induced by Fluoxetine (FLX) in the forced swimming test through interaction between...